Expert Witness to Join MediSys Corporation Clinical Advisory Board

Business Wire, Dec 19, 2005

PALM BEACH GARDENS, Fla. -- MediSys Corporation (PinkSheets:MDYS) announced today that Mr. Lee G. Hadin, of Marietta, Georgia, has accepted a seat on the Company's Clinical Advisory Board.

Mr. Hadin has 52 years of health care experience and specializes in non-invasive physiologic vascular diagnostics using ultrasound and plethysmogrophy. In addition to founding his own company Mr. Hadin was asked to help establish the electro-diagnostic department and set up the core-curriculum offered by Mary Grove College of Wayne State University in Michigan. He has written extensively on the subject of non-invasive vascular diagnostics and authored a 200 page manual describing, in detail, the various procedures relating to the topic. His vascular diagnostic manual is considered to be the definitive manual for non-invasive physiologic vascular diagnostic procedures in the field. He has been called as an expert witness in the field of non-invasive physiologic vascular diagnostics on numerous occasions including multiple times for Federal Government. Over the 26 years he has been involved in vascular diagnostics he has guest lectured nationally to numerous medical societies and medical schools on the subject and has been called in as a vascular diagnostic expert witness.

Mr. Hadin said, "I have been a vascular professional for many years, and I have never seen a program like what MediSys is offering. The quality of the work, the offer, the positioning, the market timing and the proprietary diagnostic algorithmic software are superior in every way to anything I have ever seen. I was flattered when asked to join the board. I am honored to accept this position and look forward to assisting the team."

Other appointments for Mr. Hadin include: CEO and Founder, BioSonics, one of the largest and most successful medical equipment distribution companies specializing in vascular diagnostic instrumentation in the mid-west, reaching from Minnesota to Pennsylvania with headquarters in Bloomfield Hills, Michigan. BioSonics specialized in medical ultrasound diagnostic products and services for vascular surgeons. Products included Duplex imaging, Doppler, both CE and PW, audio-spectral analysis for cerebrovascular disease, various forms of plethysmography, software for quality control in vascular diagnostics, and accessories.

The Company's Medical Director, Dr. Ralph Benson, was quoted as saying, "Lee Hadin is a wonderful addition to the team, and I believe he will add significant value to the Advisory Board. His Ultrasound teaching experience, coupled with his tenure in vascular diagnostics, where he developed and performed early clinical testing for non-invasive vascular diagnostic procedures, couldn't be more relevant to the Company's clinical goals and objectives." He also said, "I'm looking forward to working with a proven expert of Lee Hadin's caliber."

MediSys Corporation Chief Executive Officer Joshua Konigsberg remarked, "I cannot speak highly enough about this addition to our team. Lee Hadin has developed numerous Ultrasound curricula and taught non-invasive vascular diagnostics to hundreds of physicians and clinical staffs nationwide, including some of the top vascular surgeons in the country. This, coupled with his 26 year tenure in healthcare teaching and consulting, is extremely relevant to the Company's goals and objectives. His presence enhances the confidence of our physician clients and his expertise not only allows us to develop better training tools but will be extremely valuable in the recruiting of superior training staff in the future." In summary, he said, "Lee Hadin is probably the top expert in the entire USA in regards to physiologic vascular diagnostic expertise, teaching and consulting for the healthcare market."

About MediSys

MediSys Corporation provides medical diagnostic solutions to physicians in the internal medicine, family practice and general practice markets. The Company's innovative clinical programs are easily integrated into the physician's practice, are cost-effective and enhance patient care. These programs or "systems" enable doctors to provide superior medical diagnostics & treatment while significantly improving their revenues and profits.

Disclaimer Regarding Forward-Looking Statements

This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.